Effect of ramipril on the incidence of diabetes.

Effect of ramipril on the incidence of diabetes.

BACKGROUND: Previous studies have suggested that blockade of the renin-angiotensin system may prevent diabetes in people with cardiovascular disease or hypertension. METHODS: In a double-blind, randomized clinical trial with a 2-by-2 factorial design, we randomly assigned 5269 participants without...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Bosch, J, Yusuf, S, Gerstein, H, Pogue, J, Sheridan, P, Dagenais, G, Diaz, R, Avezum, A, Lanas, F, Probstfield, J, Fodor, G, Holman, R
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	2006

Eitemau Tebyg

Incidence of diabetes following ramipril or rosiglitazone withdrawal
gan: Holman, R, et al.
Cyhoeddwyd: (2011)

Incidence of diabetes following ramipril or rosiglitazone withdrawal.
gan: Investigators, D
Cyhoeddwyd: (2011)

Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial.
gan: Punthakee, Z, et al.
Cyhoeddwyd: (2012)

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
gan: Gerstein, H, et al.
Cyhoeddwyd: (2006)

Trial update: the Diabetes REduction Approaches with ramipril and rosiglitazone Medications (DREAM) trial
gan: G. Gulli
Cyhoeddwyd: (2013-05-01)

Ramipril induced pemphigoid vulgaris
gan: Mirza MA, et al.
Cyhoeddwyd: (2018-09-01)

Ramipril therapy in acute myocardial infarction
gan: V. A. Lusov, et al.
Cyhoeddwyd: (2008-10-01)

Ramipril poisoning rescued by naloxone and terlipressin
gan: Samanta Samanta, et al.
Cyhoeddwyd: (2014-01-01)

The Degradation Product of Ramipril Is Potentially Carcinogenic, Genotoxic and Mutagenic
gan: Katarzyna Regulska, et al.
Cyhoeddwyd: (2023-02-01)

Effect of ramipril on renal function in patients with intermittent claudication
gan: Simon D Hobbs, et al.
Cyhoeddwyd: (2008-04-01)

A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes
gan: Hertzel C. Gerstein, et al.
Cyhoeddwyd: (2022-08-01)

V fokuse vnimaniya - ingibitoryangiotenzinprevrashchayushchegofermenta: ramipril priarterial'noy gipertonii
gan: I E Chazova, et al.
Cyhoeddwyd: (2011-09-01)

RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION
gan: I. V. Szirov, et al.
Cyhoeddwyd: (2015-12-01)

FIXED COMBINATION OF RAMIPRIL AND HYDROCHLOROTHIAZIDE: TO WHOM AND WHAT FOR?
gan: S. V. Nedogoda
Cyhoeddwyd: (2016-09-01)

Development of Methods of Quality Control of the Tablets «Ramipril»
gan: Kateryna Typlynska, et al.
Cyhoeddwyd: (2023-04-01)

RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION
gan: I. V. Szirov, et al.
Cyhoeddwyd: (2015-12-01)

Effects of Ramipril and Rosiglitazone on Cardiovascular and Renal Outcomes in People With Impaired Glucose Tolerance or Impaired Fasting Glucose: Results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial
Cyhoeddwyd: (2008)

The place of ramipril in modern guidelines for the management of patients with cardiovascular diseases
gan: E. E. Averin, et al.
Cyhoeddwyd: (2019-01-01)

Effect of Valsartan on the Incidence of Diabetes REPLY
gan: Holman, R, et al.
Cyhoeddwyd: (2010)

RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS
gan: S. R. Willoughby, et al.
Cyhoeddwyd: (2015-12-01)

RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS
gan: S. R. Willoughby, et al.
Cyhoeddwyd: (2015-12-01)

Comparison of the efficacy, safety and tolerability of ramipril with amlodipine in treatment of mild to moderate hypertension in Nigerians
gan: B J C Onwubere, et al.
Cyhoeddwyd: (2007-01-01)

MARRIAGE: A Randomized Trial of Moxonidine Ramipril or in Combination With Ramipril in Overweight Patients With Hypertension and Impaired Fasting Glucose or Diabetes Mellitus. Impact on Blood Pressure, Heart Rate and Metabolic Parameters
gan: Paul Valensi MD, et al.
Cyhoeddwyd: (2024-06-01)

Three-dimensional printing of ramipril tablets by fused deposition modeling
gan: O. A. Terenteva, et al.
Cyhoeddwyd: (2021-12-01)

Comparative effectiveness of fixed combinations of various ramipril and hydrochlorothiazide doses
gan: I. E. Chazova, et al.
Cyhoeddwyd: (2010-08-01)

Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored.
gan: McMurray, J, et al.
Cyhoeddwyd: (2014)

THE NEW FIXED COMBINATION OF AMLODIPINE AND RAMIPRIL IN THE TREATMENT OF HYPERTENSION
gan: V. I. Podzolkov, et al.
Cyhoeddwyd: (2015-09-01)

THE NEW FIXED COMBINATION OF AMLODIPINE AND RAMIPRIL IN THE TREATMENT OF HYPERTENSION
gan: V. I. Podzolkov, et al.
Cyhoeddwyd: (2015-09-01)

Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL Study (Diabete, Ipertensione, Albuminuria, Lercanidipina)
gan: M. Dalla Vestra, et al.
Cyhoeddwyd: (1970-01-01)

RAMIPRIL EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION AND ISCHEMIC HEART DISEASE
gan: A. I. Chesnikova, et al.
Cyhoeddwyd: (2016-01-01)

Solid-State Stability Profiling of Ramipril to Optimize Its Quality Efficiency and Safety
gan: Katarzyna Regulska, et al.
Cyhoeddwyd: (2021-10-01)

ESTIMATION OF NEPHROPROTECTIVE EFFECT OF ANGIOTENSIN-CONVERTING ENZYME RAMIPRIL IN PATIENTS WITH CHRONIC GLOMERULONEPHRITIS
gan: M.A. Dolinnayä, et al.
Cyhoeddwyd: (2017-03-01)

CHANGES IN CLINICAL MANIFESTATION OF CONGESTIVE HEART FAILURE AT THE BACKGROUND OF REGULAR RAMIPRIL INTAKE
gan: A. G. Kuzmin, et al.
Cyhoeddwyd: (2014-08-01)

Efficiency (advantages) of ramipril in arterial hypertension and diabetes mellitus from the point of view of evidence-based medicine
gan: M. V. Leonova
Cyhoeddwyd: (2020-05-01)

CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL
gan: D. A. Napalkov, et al.
Cyhoeddwyd: (2016-01-01)

DISSOLUTION PROFILE STUDIES FOR RAMIPRIL AND LERCANIDIPINE FIXED-DOSE COMBINATION
gan: A. A. Shadrin, et al.
Cyhoeddwyd: (2019-01-01)

The effects of sacubitril/valsartan and ramipril on the male fertility in hypertensive rats
gan: Duygun Altıntaş Aykan, et al.
Cyhoeddwyd: (2020-10-01)

CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL
gan: D. A. Napalkov, et al.
Cyhoeddwyd: (2016-01-01)

Modern antihypertensive therapy: the effectiveness of a unique Russian fixed-dose combination of ramipril and indapamide
gan: A. O. Konradi, et al.
Cyhoeddwyd: (2020-04-01)

Development and validation of a stability indicating UPLC-DAD method coupled with MS-TQD for ramipril and thymoquinone in bioactive SNEDDS with in silico toxicity analysis of ramipril degradation products
gan: Elzayat Ehab M., et al.
Cyhoeddwyd: (2024-08-01)